http://www.nkartatx.com
Nkarta, Inc. Company Intro
Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.
Industry
Healthcare
Nkarta, Inc. Headquaters
6000 Shoreline Court
South San Francisco,94080
United States
Nkarta, Inc. Share price
17 May 2023 13:36 GMT
$4.5500
0.06 (1.34 %)
Nkarta, Inc. Market cap
$212.867 M
WMC RANKING
2024
Nkarta, Inc. # 383
BiotechnologyLatest Nkarta, Inc. News
12 Feb 2024
Nkarta (NASDAQ:NKTX) Sets New 12-Month High at $12.20
Shares of Nkarta, Inc. (NASDAQ:NKTX - Get Free Report) reached a new 52-week high on Monday . The company traded as high as $12.20 and last traded at $12.15...
12 Feb 2024
Will Nkarta Inc (NKTX) Stay at the Top of the Healthcare Sector?
Nkarta Inc (NKTX) is near the top in its sector according to InvestorsObserver. NKTX gets an overall rating of 82. That means it scores higher than 82% of...
12 Feb 2024
Nkarta (NASDAQ:NKTX) Sets New 12-Month High at $12.20
Shares of Nkarta, Inc. (NASDAQ:NKTX - Get Free Report) reached a new 52-week high on Monday . The company traded as high as $12.20 and last traded at $12.15...
WMC Market Score
WMC Market to Revenue Score
Nkarta, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Nkarta, Inc. | USD | $0 | $61,581 | $-102,028 | $2,129M | 383 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Nkarta, Inc. Social Followers vs Top 4 Industry Competitors
Nkarta, Inc. Post vs Top 4 Industry Competitors
Nkarta, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Nkarta, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Nkarta, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Nkarta, Inc. | 0.00 | 2.28 | 0 | 0 | 0 | 0 | 0.81 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
